Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | CASR | P41180 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL7027623 | 0.88 | MEN1 (0.57) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| SCHEMBL7022145 | 0.78 | MEN1 (0.47) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| SCHEMBL7033981 | 0.78 | MEN1 (0.70) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| SCHEMBL6327240 | 0.78 | MEN1 (0.70) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| Hydrochloric Acid SCHEMBL7027080 | 0.77 | MEN1 (0.68) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| Phosphoric Acid SCHEMBL7022139 | 0.74 | MEN1 (0.64) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| Sulfuric Acid SCHEMBL7025416 | 0.74 | MEN1 (0.64) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| Sulfuric Acid SCHEMBL7598698 | 0.74 | MEN1 (0.64) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| SCHEMBL6321097 | 0.71 | ABCB1 (0.49) | MEN1OPRM1OPRD1KMT2AABCB1 | |
| SCHEMBL7536027 | 0.70 | ADRB3 (0.62) | MEN1OPRM1OPRD1KMT2AABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030032834-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032834-A1 | Aminoalcohol derivatives | ADRB1, ADRB2, ADRB3 | MEN1 4166/4885OPRM1 35/4885OPRD1 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.